Showing results (261-270 of 672) with videos related to

Sort By:
Pageof 68
Influenza and Other Respiratory Viruses|February 27, 2026
Diagnostic Performance of Self-Collected Respiratory Swabs for SARS-CoV-2 and Influenza Virus in Community-Dwelling Older AdultsXinyi Li, Samuel M S Cheng, Yuyun Chen, et al.
Nature Communications|June 5, 2026
SARS-CoV-2 Omicron BA.2.86 and JN.1 expand tropism in human proximal intestinal epitheliumKenrie Py Hui, John Cw Ho, Ka-Chun Ng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in miceLeo L M Poon, Y H Connie Leung, John M Nicholls, et al.
The Journal of Infectious Diseases|March 29, 2014
Association between antibody titers and protection against influenza virus infection within householdsTim K Tsang, Simon Cauchemez, Ranawaka A P M Perera, et al.
The Journal of Biological Chemistry|August 15, 2003
The severe acute respiratory syndrome (SARS) coronavirus NTPase/helicase belongs to a distinct class of 5' to 3' viral helicasesJulian A Tanner, Rory M Watt, Yu-Bo Chai, et al.
The Journal of Infectious Diseases|January 27, 2026
Influenza vaccination effectiveness against influenza-associated hospitalization in children and the effects of repeated vaccinationXuan Yu, So-Lun Lee, Mike Y W Kwan, et al.
The Journal of General Virology|July 31, 2025
Evaluation of pandemic potential of the genotype 4 (G4) swine influenza virus using ex vivo and in vitro cultures of the human respiratory tractJenny C M Chan, Rachel H H Ching, Hermione H M Kock, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 5, 2019
Middle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018Anass Abbad, Ranawaka Apm Perera, Latifa Anga, et al.
Environmental Health Perspectives|May 13, 2022
Use of Sewage Surveillance for COVID-19: A Large-Scale Evidence-Based Program in Hong KongYu Deng, Xiawan Zheng, Xiaoqing Xu, et al.
Pageof 68